How much is a First Class stamp? <a href="http://www.intebuild.com/index.php/stmap_55960.html?levitra.trimox.venlor">chewing a 12 mg fentanyl patch</a>  Alirocumab is an investigational, fully-human monoclonal antibody that targets and blocks PCSK9. It is administered via subcutaneous injection. By inhibiting PCSK9, a determinant of circulating LDL-C levels in the blood, alirocumab has been shown in pre-clinical studies to increase the number of LDL receptors on hepatocytes, thereby lowering LDL-C.